These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 119520)

  • 1. Dentistry: controlled substances and enforcement.
    Hankins HH
    Ark Dent J; 1979 Jun; 50(2):12-5. PubMed ID: 119520
    [No Abstract]   [Full Text] [Related]  

  • 2. Issuance of multiple prescriptions for schedule II controlled substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2007 Nov; 72(222):64921-30. PubMed ID: 18038486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1991 Jun; 56(106):25025-7. PubMed ID: 10111144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An American Medical Association perspective on preventing prescription drug diversion.
    Ambre JJ
    NIDA Res Monogr; 1993; 131():224-7. PubMed ID: 8413533
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for prescribers of controlled substances.
    Wis Med J; 1981 Jun; 80(6):53-4. PubMed ID: 7257443
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescriptions; dispensing controlled substances in institutional practitioner emergency rooms--Drug Enforcement Administration, Justice. Withdrawal of proposed rule.
    Fed Regist; 1983 Jun; 48(125):29713-4. PubMed ID: 10261481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances.
    Joranson DE
    NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529
    [No Abstract]   [Full Text] [Related]  

  • 8. DEA issues proposed rule on e-prescribing.
    Ball FR
    J Med Pract Manage; 2009; 24(4):243. PubMed ID: 19288650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for prescribers of controlled substances. A joint statement of the Drug Enforcement Administration and the DEA/Practitioners Working Committee.
    Ohio State Med J; 1981 May; 77(5):312-3. PubMed ID: 7254747
    [No Abstract]   [Full Text] [Related]  

  • 10. The DEA issues new clarification regarding prescribing schedule II controlled substances.
    Heitz R
    WMJ; 2005 Apr; 104(3):55. PubMed ID: 15966635
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescriptions for Schedule II controlled substances: Drug Enforcement Administration, Justice. Notice of proposed rulemaking.
    Fed Regist; 1980 Apr; 45(70):24199-200. PubMed ID: 10246081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicines and related substances act.
    SADJ; 2012 Sep; 67(8):468-9. PubMed ID: 23951814
    [No Abstract]   [Full Text] [Related]  

  • 13. E-prescribing for controlled substances.
    Tenn Med; 2005 Dec; 98(12):561. PubMed ID: 16401046
    [No Abstract]   [Full Text] [Related]  

  • 14. Dear DEA.
    Heit HA; Covington E; Good PM
    Pain Med; 2004 Sep; 5(3):303-8. PubMed ID: 15367311
    [No Abstract]   [Full Text] [Related]  

  • 15. What is being done to address the new drug epidemic?
    Dekker AH
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES21-6. PubMed ID: 17908827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DEA proposes schedule II substance rule.
    Buchanan BL
    WMJ; 2007 Jul; 106(4):230. PubMed ID: 17844715
    [No Abstract]   [Full Text] [Related]  

  • 17. Summary and conclusions of a review of prescription drug diversion control methods.
    Horgan C; Prottas J; Tompkins C; Wastila L; Bowden M
    NIDA Res Monogr; 1993; 131():206-23. PubMed ID: 8413532
    [No Abstract]   [Full Text] [Related]  

  • 18. Triplicate prescription: issues and answers. Introduction.
    Farnsworth PB
    N Y State J Med; 1991 Nov; 91(11 Suppl):1S-4S. PubMed ID: 1771052
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of drug regulations and diversion control systems on legitimate narcolepsy patients.
    Piscopo JA
    NIDA Res Monogr; 1993; 131():249-59. PubMed ID: 8105384
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for prescribers of controlled drugs.
    Phillips D
    J Ark Med Soc; 1985 Feb; 81(9):463-4. PubMed ID: 3156117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.